Publication & Citation Trends
Publications
0 total
M 118 – A rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromes
Cited by 0
Semantic Scholar
M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis OA
Cited by 165
Semantic Scholar
Abstract 2269: M402 - A novel heparan sulfate proteoglycan mimetic targeting tumor-host interactions
Cited by 0
Semantic Scholar
A rationally designed heparin, M118, has anticoagulant activity similar to unfractionated heparin and different from Lovenox in a cell-based model of thrombin generation
Cited by 5
Semantic Scholar
M118 – A rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromes
Cited by 15
Semantic Scholar
Genetically engineered mouse melanoma and mouse Lewis lung carcinoma models.
Cited by 1
Semantic Scholar
Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route. OA
Cited by 59
Semantic Scholar
Rational design of low-molecular weight heparins with improved in vivo activity OA
Cited by 85
Semantic Scholar
Research Topics
Cancer-related molecular mechanisms research
(4)
RNA modifications and cancer
(4)
Glioma Diagnosis and Treatment
(3)
Pituitary Gland Disorders and Treatments
(3)
Proteoglycans and glycosaminoglycans research
(3)
Affiliations
Dalian Medical University
First Affiliated Hospital of Dalian Medical University
Bioengineering Center
Tongji Hospital
Huazhong University of Science and Technology